Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Wear and Tear: A Breakdown of Degenerative Comorbid Conditions

With the workforce growing older, degenerative conditions may have a growing impact on claims.
Winter 2025/2026

Creeping Costs: The Rise of Mega Claims in Workers’ Compensation

A small percentage of claims are driving the majority of costs in workers’ comp. What are these “mega claims” and how can we mitigate them?
Winter 2025/2026

INFOGRAPHIC: Current State of Complex Claims in Workers’ Comp

Statistics from recent studies across the industry shed light on complex claims in workers' compensation.
Winter 2025/2026

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

White House Announces Deal to Expand Access to GLP-1 Medications

Qualifying CMS patients could pay as little as $50 a month for Ozempic or Wegovy.
Nov 2025

Common Exceptions: The Rising Incidence of Complex Claims in Workers’ Compensation

Understanding the factors that drive longer claim duration and higher costs.
Nov 2025

California to Expedite Research Around Schedule I & II Drugs

Assembly Bill 1103 was enacted, allowing for the Research Advisory Panel to expedite the review and approval of research applications.
Nov 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

JAMA Study Notes Possible Cardiovascular Benefits for GLP-1 Antagonists

Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.
Nov 2025

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.
Oct 2025

CWCI Study Finds Poor Performance Across Functional Restoration Programs

Claims in FRPs cost 59% more, likely tied to a gap between guideline recommendations and how FRPs are managed.
Oct 2025
1 2 3 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle